Welcome to BARBRI, the trusted global leader in legal education. Continue to access the same expert-led Strafford CLE and CPE webinars you know and value. Plus, explore professional skills courses and more.
About the Course
Introduction
This CLE webinar will discuss the admissibility of epidemiological evidence in toxic tort, medical device, and pharmaceutical product liability cases. The panel will review the proper role of epidemiology in showing general causation and how to challenge studies and experts under Federal Rule of Evidence 702 and Daubert.
Description
In every toxic tort, medical device, and pharmaceutical product liability case, a threshold issue is whether the product, device, or substance is even capable of causing the alleged harm in some part of the population. To establish this, lawyers rely first and foremost on epidemiological experts and research, the "gold standard" of general causation evidence. Causation, however, is a continuum, and no single study can prove causation.
If the plaintiff's epidemiological testimony and related studies are excluded under Federal Rule of Evidence 702 and Daubert, the litigation will most likely end, or at least be significantly narrowed. Thus, admissibility under FRE 702 and Daubert is fiercely litigated in most cases.
Courts are increasingly taking a "hard look" at experts' methodologies and assessing whether the expert's opinion reflects a reliable application of the principles and methods to the facts of the case. For example, courts are analyzing experts' logic, asking if their final opinions exceed the limits of applicable studies, and being sensitive to when experts are "cherry-picking" the evidence to fit the desired conclusions.
Listen as this esteemed panel of product liability litigators discusses the admissibility of epidemiological evidence in toxic tort, medical device, and pharmaceutical product liability cases
Presented By
Mr. Campbell is the Chair of DLA Piper's Product Liability and Mass Tort practice group, awarded "Practice Group of the Year" in 2025 by Law360, ranked Band 1 by Chambers, and ranked Tier 1 by The Legal 500. He is also Co-Chair of the Product Liability, Mass Torts & Class Actions group. A graduate of Harvard Law School, Mr. Campbell has 25 years' experience in all phases of mass tort, class action, and other product liability complex commercial litigation, serving as global, national, and trial counsel for many global companies across industries. He also advises clients on regulatory, communications, and other strategic matters that impact the clients' business interests or reputations. Forbes recently recognized Mr. Campbell as "best in state" in Georgia, the only product liability lawyer to receive this recognition in the state. He regularly speaks and writes on the topics of product liability, mass torts, and class action litigation, as well as the attorney-client privilege, expert witnesses, pharmacovigilance, trial tactics, and other topics. Mr. Campbell is the co-author of the book, Expert Witnesses in Product Liability Cases.
Ms. Carrier is a litigation lawyer with experience in government, law firm, and corporate legal department roles. Her practice focuses on defending international corporations in complex litigation, primarily in the consumer products, pharmaceutical, and women's health sectors. Ms. Carrier's experience arguing before state, federal, and bankruptcy courts help her guide companies in all phases of case management and trial preparation. She also advises clients in a wide variety of non-dispute matters, including product development and compliance.
Mr. Castile focuses his practice on complex commercial litigation matters, assisting with all stages of legal proceedings in state and federal courts by conducting legal research and drafting memoranda, motions and briefs, and facilitating pre-trial discovery, document production, and trial preparation. His experience includes preparing and presenting oral arguments, conducting and defending depositions, and advocating at mediations and at trial. Mr. Castile manages complex litigation from inception through trial. He develops and executes effective defense strategies in a range of matters, including presenting witnesses and delivering closing arguments before federal juries. In addition to his trial experience, Mr. Castile recognizes the value of dispute resolution and has guided clients through judicial and non-judicial mediations, as well as alternative dispute resolution processes such as mediation and arbitration.
Mr. McConnell defends clients in product liability and mass tort litigation. He has also handled securities litigation, complex commercial litigation, and white-collar criminal litigation. He is a former Assistant U.S. Attorney with ample first-chair experience in both government and private practice cases and has successfully argued significant matters before federal and state trial and appellate courts. Mr. McConnell has represented consumer products manufacturers and leading global medical device and pharmaceutical companies, including Wyeth, for whom he served as first-chair trial counsel in the diet drug litigation.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Tuesday, March 14, 2023
- schedule
1:00 p.m. ET./10:00 a.m. PT
- General, specific, and legal causation
- Role of differential diagnosis
- Science of epidemiology and the hierarchy of evidence
- Association vs. causation
- Bradford Hill criteria
- International Agency for Research on Cancer (IARC)
- Assessing admissibility under FRE 702
- Assist trier of fact
- Sufficient facts or data
- Product of reliable principles and methods
- Expert has reliably applied the principles and methods to the facts of the case
- Daubert criteria for scientific evidence
- Strategies for plaintiffs and defendants
The panel will discuss these and other key issues:
- What is epidemiology?
- Can epidemiological studies support specific causation?
- When considering admissibility, does rebuttal expert evidence have to meet the same standards as the plaintiff's evidence?
- What factors show that an expert's opinion does not reflect a reliable application of the principles and methods to the facts of the case?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
Litigation Holds: Satisfying the Duty to Preserve Evidence
Tuesday, January 12, 2027
1:00 PM ET/10:00 AM PT
Complex Products Cases: Excluding Epidemiological Evidence Under FRE 702 and Impact of Acetaminophen-Autism Cases
Tuesday, January 26, 2027
1:00 PM ET/10:00 AM PT
Ethical Witness Preparation Under ABA Formal Opinion 508
Available On-Demand
Recommended Resources
International Law: Why Global Legal Developments Matter More Than Ever
- Learning & Development
Personal Injury and Medical Malpractice: Key Issues Lawyers Need to Follow
- Learning & Development